The listing below shows our latest News Items and is updated regularly. If you wish to post a news item please select the 'Post News' button on the right. The displayed news feed starts on 1st August 2016. Older items can be found here.
AMSBIO announces the launch of two new microplate-based metabolism stress kits enabling characterization of the main parameters of mitochondrial function in live cells and evaluation of the glycolytic response ofin vitro cell models to metabolic stress.
Read the rest of entry »
AMSBIO announces the launch of two new microplate-based metabolism stress kits enabling characterization of the main parameters of mitochondrial function in live cells and evaluation of the glycolytic response of in vitro cell models to metabolic stress
Announced that it plans to release third quarter 2017 financial results prior to market open.
Oxford, UK: Genomics plc today announced that it has entered into a collaborative deal with Biogen, Inc., the U.S.-based biotech, to work on multiple sclerosis (MS). Biogen is an international leader in drug therapies for MS, with the broadest MS portfolio in the industry.
Summit Highlights Microbiome Preservation During Ridinilazole Treatment in Exploraroty Phase 2 Clinical Trial at ID Week 2017
Enesi Pharma, a clinical-stage company developing unique injectable solid dose drug-device combination products, announces its launch as a new company at the World Vaccine Congress
Novel materials enablecontrolled and sustained release of chlorhexidine across a multitude of applications
Leading Contract Development and Manufacturing Organization (CDMO), announced investments of $55 million across its sites in North America & Asia, to expand its API manufacturing capabilities and capacities.
OBN Awards 2017 – Winners Recognised at Industry Leading Event
Abingdon, UK, 6 October 2017: – OBN (UK) Ltd, the membership organisation that supports the life sciences industry, are delighted to announce the winners of the prestigious OBN Awards 2017 that were presented last night in front of a sold-out audience of over 250 life science industry leaders at the Town Hall in Oxford.
The Awards, which are in their 9th year, celebrate the best of UK life sciences – from outstanding scientific innovation within biotech, medtech, digital, synthetic biology, to the companies that support the industry and the fundraisers that make it happen.
John Harris, CEO of OBN, said: “We received an outstanding number of entries this year; up a staggering 120% on last year, so competition was really tough. All of our winners and nominees this year are truly innovative and set a great example to the rest of the industry. We ...
“The Company features alongside The Prime Minister, The Rt Hon Theresa May MP, and a small number of outstanding organisations in the Technology edition”
OBN aims to provide sector NEWS that is relevant to our Membership. We filter information from a variety of sources, publish items ourselves and will publish items of News from our Members. Press releases about OBN can be found here.
This is an impromptu noticeboard to let people know about events, other things that are happening, perhaps lab equipment for sale etc. Just drop an email to us, firstname.lastname@example.org, and we will post.